Solid Biosciences Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2020 | $17.5M | $74.0M | $53.2M |
| Jun 2020 | $17.3M | $58.0M | $40.4M |
| Sep 2020 | $18.3M | $40.5M | $24.8M |
| Dec 2020 | $39.1M | $171.2M | $154.7M |
| Mar 2021 | $32.3M | $285.3M | $268.5M |
| Jun 2021 | $27.9M | $265.9M | $200.6M |
| Sep 2021 | $25.6M | $249.0M | $109.7M |
| Dec 2021 | $24.2M | $232.4M | $119.1M |
| Mar 2022 | $22.0M | $207.6M | $129.7M |
| Jun 2022 | $46.3M | $208.5M | $54.3M |
| Sep 2022 | $41.2M | $184.5M | $48.8M |
| Dec 2022 | $48.6M | $260.3M | $155.4M |
| Mar 2023 | $45.8M | $229.6M | $164.6M |
| Jun 2023 | $41.0M | $204.7M | $91.6M |
| Sep 2023 | $40.4M | $184.7M | $49.0M |
| Dec 2023 | $38.5M | $164.9M | $74.0M |
| Mar 2024 | $38.0M | $248.7M | $117.6M |
| Jun 2024 | $37.7M | $231.0M | $95.9M |
| Sep 2024 | $44.8M | $211.8M | $64.4M |
| Dec 2024 | $51.4M | $188.7M | $80.2M |